Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rescue of Progranulin Haploinsufficiency in Frontotemporal Dementia
2011-004571-37Phase 2Active
- Sponsor
- ASST Spedali Civili di Brescia
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of amiodarone in frontotemporal dementia (FTD), sponsored by ASST Spedali Civili di Brescia. Primary endpoint: Disease progression modification. Started Feb 2012; status: active.
02
Drugs
amiodarone
03
Conditions
frontotemporal dementia (FTD)
Beyond the preview
Go deeper on 2011-004571-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004571-37.